Search - tctmd.com

Displaying 421 - 440 of 444

Sort: Relevancy | Date

News Daily News

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

June 01, 2012

Presentation

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Presenter: Vivek Y. Reddy

May 30, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Industry News

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

March 20, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

News Daily News

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

Jason Kahn

March 05, 2012

Presentation

The Clinical Impact of Incomplete LAA Closure With the Watchman Device in Patients With A-fib

Presenter: J. Viles-Gonzalez

February 26, 2012

Presentation

Impacto Clínico del Cierre Incompleto del AAI con el Dispositivo Watchman en Pacientes con Fibrilación Auricular

Presenter: J. Viles-Gonzalez

February 26, 2012

Presentation ISET 2012

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Presenter: Ramon Quesada

January 16, 2012

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Industry News

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

November 01, 2011

News Daily News

Commentary Authors Urge Improvements to Device Approval Process

Caitlin E. Cox

July 20, 2011

News Industry News

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

May 18, 2011

News Industry News

Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech

March 02, 2011

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

News Industry News

Boston Scientific to Acquire Atritech

January 18, 2011

Video

» Live Case

LIVE Case 11: WATCHMAN FLX LAAO Integrated Sheath - Tucson Medical Center - Tucson, AZ

July 7, 2023

Video

» Interview

AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

November 5, 2021

Video

» Interview

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

November 5, 2021

Advertisement

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

The Clinical Impact of Incomplete LAA Closure With the Watchman Device in Patients With A-fib

Impacto Clínico del Cierre Incompleto del AAI con el Dispositivo Watchman en Pacientes con Fibrilación Auricular

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

Commentary Authors Urge Improvements to Device Approval Process

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Boston Scientific to Acquire Atritech

LIVE Case 11: WATCHMAN FLX LAAO Integrated Sheath - Tucson Medical Center - Tucson, AZ

AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content